Brachytherapy for eyelid cancers: Re-defining outcomes and esthetics in rare histologies
Adjuvant HDR brachytherapy is a safe and effective treatment for eyelid malignancies, achieving excellent local control, superior cosmetic outcomes, and acceptable toxicity. This modality optimizes tumor control, while preserving function and esthetics in this anatomically sensitive region.
Authors
- Shrikant Kale (ORCID: https://orcid.org/0000-0002-5114-6769)
- Anuj Kumar (ORCID: https://orcid.org/0000-0001-9660-1510)
- Prashasti Sharma (ORCID: https://orcid.org/0009-0001-7186-0003)
- Muhammed Anaz
- Monali Swain (ORCID: https://orcid.org/0000-0002-8111-4127)
- Shwetabh Sinha (ORCID: https://orcid.org/0000-0003-3369-3870)
- Samarpita Mohanty (ORCID: https://orcid.org/0000-0002-8037-957X)
- Ashwini Budrukkar
- Sarbani Ghosh Laskar
Institutions
- Homi Bhabha National Institute (IN)
- Tata Memorial Hospital (IN)
Publication Details
- Journal
- Journal of Contemporary Brachytherapy
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5114/jcb.2025.152540
- Primary Topic
- Nonmelanoma Skin Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00